Clinical Trials on Glabellar Crease in New Zealand
Total 2404 results
-
PfizerTerminatedBreast NeoplasmsSpain, Korea, Republic of, United States, Australia, Italy, Russian Federation
-
Hoffmann-La RocheActive, not recruitingLocally Advanced or Metastatic Breast CancerUnited States, Spain, Taiwan, France, Argentina, Belgium, China, Germany, Saudi Arabia, Thailand, United Kingdom, Colombia, Poland, India, Portugal, Hungary, Mexico, Lebanon, Jordan, Kenya, Brazil, Italy, Oman, Egypt, South Korea, Turkey... and more
-
National Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Endometrial Cancer | Thyroid Cancer | Colorectal Cancer, MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Colorectal Cancer | Lung Cancer | Bladder CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedKidney Cancer | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Non-small Cell Lung Cancer | GliomasUnited States
-
Merck Sharp & Dohme LLCDaiichi SankyoRecruitingBreast NeoplasmsCanada, Argentina, United States, Taiwan, Israel, Brazil, South Korea, Japan, France, Spain, China, Turkey (Türkiye), Italy, Hungary, Poland, Colombia, Greece, Australia, Chile, Thailand, Mexico, Germany, United Kingdom, Hong Kong, Peru
-
ExelixisCompletedCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Australia, Belgium, France, Italy, Korea, Republic of, Netherlands, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, Italy, Spain, United Kingdom, Austria, Czechia, Hungary, Malaysia, Saudi Arabia, Taiwan, Argentina, France, Israel, Netherlands, Russian Federation, Hong Kong, Thailand, Lebanon, Bulgaria, Denmark, Po... and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); PfizerTerminatedPain | Breast Cancer | Colorectal CancerUnited States, Puerto Rico
-
Hoffmann-La RocheCompletedBreast CancerChina, Hong Kong, France, Spain, Italy, Turkey, Brazil, Egypt, Poland, India, Saudi Arabia
-
Intarcia TherapeuticsCompletedBreast Neoplasms | Neoplasms, Hormone-dependentUnited States, Canada, Russian Federation, Ukraine
-
Cyteir Therapeutics, Inc.CompletedSoft Tissue Sarcoma | Follicular Lymphoma | Breast Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Multiple Myeloma | Pancreatic Cancer | Ovarian Cancer | Mantle Cell Lymphoma | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | DLBCL | Non-hodgkin Lymphoma | Malignancy | CLLUnited States
-
Northwell HealthCompletedCoronary Artery Disease | Lymphoma | Cancer | Breast Cancer | Lung Cancer | Cardiotoxicity | Cardiac Disease | Carcinoma, Intraductal, Noninfiltrating | Cardiac Toxicity | Radiation | Radiation Therapy | Atherosclerotic Heart DiseaseUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
NRG OncologyNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Prostate Adenocarcinoma | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Male Breast CarcinomaUnited States, Canada, Switzerland
-
TCR2 TherapeuticsActive, not recruitingColorectal Neoplasms | Colorectal Cancer | Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Ovarian Neoplasms | Ovarian Cancer | Non Small Cell Lung Cancer | Mesothelioma | Mesothelioma, Malignant | Cholangiocarcinoma | Triple Negative Breast Cancer | Ovarian Adenocarcinoma | Mesotheliomas Pleural and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, India, Spain, United Kingdom, Germany, Taiwan, Australia, Italy, Austria, Canada, Israel, Russian Federation, Korea, Republic of, Thailand, Hungary, Japan, Lebanon, Belgium, Bulgaria, Greece, Czechia, Argentina, France, Per... and more
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerChina, Australia, United Kingdom, Argentina, Germany, Singapore, Taiwan, United States, Thailand, Ukraine, Israel, South Africa, Poland, Brazil, South Korea, Turkey (Türkiye), Russia
-
GE HealthcareQuintiles, Inc.; i3 Statprobe; BIAFFIN GmbH & Co. KG (Biomolecular Interaction...CompletedSarcoma | Renal Cell Carcinoma | Breast Cancer | Head and Neck Cancer | Lung Cancer | Solid Tumors | High Grade GliomasUnited States
-
Medtronic - MITGCompletedObesity | Breast PtosisUnited States, Germany
-
Hummingbird BioscienceRecruitingBreast Cancer | Non Small Cell Lung Cancer | Melanoma (Skin)United States, Australia
-
Iambic Therapeutics, IncRecruitingHER2-positive Breast Cancer | HER2-positive Colorectal Cancer | CNS Metastases | HER2 Mutation-Related Tumors | HER2-Positive Solid Tumors | HER2 | NSCLC (Non-small Cell Lung Cancer) | HER2-positive Bladder Cancer | Brain Metastases From HER2 and Breast Cancer | HER2 + Breast Cancer | HER2 + Gastric Cancer | Brain Metastases From Solid Tumors and other conditionsUnited States, Spain, France, Italy, Ireland, South Korea, Netherlands, United Kingdom
-
Eli Lilly and CompanyEli Lilly and CompanyApproved for marketingBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationUnited States, Poland, Australia, Japan, France, Spain, Germany, Italy, Hong Kong, New Zealand, Singapore, Israel, Switzerland
-
Celcuity IncActive, not recruitingBreast CancerUnited States, Taiwan, France, United Kingdom, Belgium, Spain, Singapore, Greece, India, Australia, Germany, Canada, Italy, Romania, Argentina, Czechia, South Korea, Austria, Brazil, Bulgaria, Hungary, Mexico, Poland
-
AgendiaCompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
PfizerTerminatedHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Bulgaria, Ukraine, Russia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedTriple-negative Breast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedBreast Carcinoma | Estrogen Receptor Negative | Progesterone Receptor NegativeUnited States, Guam
-
Merck Sharp & Dohme LLCCompletedTriple Negative Breast NeoplasmsUnited States, Canada, France, Germany, Hungary, Ireland, Japan, Spain, Taiwan, Ukraine, United Kingdom, South Korea, Chile, Colombia, Poland
-
Novartis PharmaceuticalsCompletedBreast CancerChina, United States, France, Italy, United Kingdom, Taiwan, Turkey, Egypt, Germany, Hong Kong, Belgium, Canada, Russian Federation, Lebanon, Japan, Australia, Greece, Korea, Republic of, Ireland, Peru, Argentina, Brazil, Colombia, South... and more
-
Intarcia TherapeuticsTerminatedBreast Neoplasms | Neoplasms, Hormone-DependentUnited States, Romania, Russian Federation, Ukraine, Bulgaria
-
Novartis PharmaceuticalsCompletedBreast Cancer | Advanced Solid Tumors | Cowden SyndromeNetherlands, Spain, Germany, United Kingdom, United States
-
Janssen Research & Development, LLCCompletedBreast Cancer | Neoplasm MetastasisUnited States, Poland, Ukraine, Taiwan, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Russian Federation, South Africa, Hong Kong, Chile, Brazil, Philippines, Ecuador, Macedonia, The Former Yugoslav Republic... and more
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Beth Israel Medical CenterCompletedCervical Cancer | Breast Cancer | Lung Cancer | Prostate Cancer | Colon CancerUnited States
-
Immix Biopharma Australia Pty LtdActive, not recruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Solid Tumor, AdultUnited States, Australia
-
R-PharmCompletedBreast Cancer | MetastasesUnited States, Netherlands, Argentina, Canada, South Africa, Mexico, Norway, Sweden, France, Germany
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.Active, not recruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Canada, Japan
-
Hoffmann-La RocheTerminatedBreast CancerItaly, United States, Korea, Republic of, Canada, Czechia, Spain, Australia, Bulgaria, China, Finland, France, Greece, Poland, Portugal, Taiwan, Thailand, Turkey, Colombia, Bosnia and Herzegovina, Mexico, Peru, Romania, Russian Federation and more
-
Compass TherapeuticsRecruitingHodgkin Lymphoma | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Malignant MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage III Renal Cell Cancer | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Epithelial Cancer | Stage IIIB Breast Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell... and other conditionsUnited States
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Denmark, Germany, Spain, Italy, Brazil
-
Hoffmann-La RocheCompletedBreast NeoplasmsHungary, Italy, United Kingdom, Canada, Czechia, Bulgaria, Croatia, Dominican Republic, France, Germany, Greece, Guatemala, Hong Kong, Indonesia, Ireland, Korea, Republic of, Netherlands, Panama, Peru, Poland, Portugal, Slovakia, Spain and more
-
Greenwich LifeSciences, Inc.RecruitingBreast CancerFrance, United States, Spain, Germany, Italy, Poland, Ireland, Romania
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingBreast Carcinoma | Mastectomy PatientUnited States
-
Stony Brook UniversityThe University of Texas Health Science Center at San AntonioRecruitingMetastatic Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastasis | Spine Metastases | Metastatic Tumor | Metastatic Tumor of Bone | Metastatic Tumor to the SpineUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, South Africa, Austria, Hungary, Germany, Czechia, France, Thailand, Belgium, Bulgaria, Lithuania, Jordan, Sweden, Colombia, Finland, Portugal, Canada, India, Argentina, Peru, Russia, Brazil, Costa Rica
-
Rondo TherapeuticsEnrolling by invitationCervical Cancer | Cancer | Gastric Cancer | Non Small Cell Lung Cancer | Urothelial Carcinoma Bladder | Head and Neck Squamous Cell Cancer | Esophageal Squamous Cell Cancer | Triple Negative Breast Cancer (TNBC) | Gastroesophageal Junction (GEJ) Adenocarcinoma | Solid Tumors (Phase 1)United States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, China, Belgium, Canada, France, Italy, Taiwan, United Kingdom, Hungary, Australia, Spain, Germany, Singapore, Austria, Japan, Israel, Russian Federation, Korea, Republic of, Thailand, Slovakia, South Africa, Switzer... and more